2024 AACR 会议：Calidi Biotherapeutics 展示基于同种异体干细胞的病毒治疗免疫疗法的数据。 2024 AACR Meeting: Calidi Biotherapeutics presents data on allogeneic stem cell-based virotherapy immunotherapies.

2024 AACR 会议：Calidi Biotherapeutics 在其新型免疫疗法中展示了有关载病毒疗法的干细胞的作用机制的新数据。 2024 AACR Meeting: Calidi Biotherapeutics presents new data on the mechanisms of action for virotherapy-loaded stem cells in its novel immunotherapies. 该公司采用同种异体干细胞的方法被认为使其技术与众不同，并为癌症患者提供通用的现成治疗选择。 The company's approach, using allogeneic stem cells, is believed to differentiate its technology and offer potential for universal, off-the-shelf options for cancer patients. 数据将于 4 月 9 日在圣地亚哥的 AACR 上公布。 Data will be presented on Apr 9 at AACR in San Diego.

文章

Street Insider

Market Screener

WallStreet Online

-- 显示更少 --

延伸阅读

相关故事